Biological and Clinical Relevance of Quantra Viscoelastic Hemostatic Assay in Hemorrhagic Cardiac Surgery

RecruitingOBSERVATIONAL
Enrollment

600

Participants

Timeline

Start Date

July 10, 2025

Primary Completion Date

July 9, 2026

Study Completion Date

August 10, 2026

Conditions
HemorrhageCardiac SurgeryHemorrhagic Shock
Interventions
DIAGNOSTIC_TEST

Viscoelastometric hemostatic assay

As part of usual care, when weaning the patient from CPB during cardiac surgery, blood samples are withdrawn from the patient to assess hemostasis: we test both Quantra viscoelastometric assay and biological hemostasis including QT, ACT, fibrinogen and platelet count

Trial Locations (1)

75013

RECRUITING

Pitié-Salpêtrière Hospital, Paris

All Listed Sponsors
lead

Pitié-Salpêtrière Hospital

OTHER

NCT07105904 - Biological and Clinical Relevance of Quantra Viscoelastic Hemostatic Assay in Hemorrhagic Cardiac Surgery | Biotech Hunter | Biotech Hunter